Syngene International Limited (NSE:SYNGENE)
India · Delayed Price · Currency is INR 703.25
-10.75 (-1.51%)
Aug 1, 2025, 3:29 PM IST
Theseus Pharmaceuticals Market Cap
Syngene International has a market cap or net worth of 279.96 billion as of August 1, 2025. Its market cap has decreased by -6.39% in one year.
Market Cap
279.96B
Enterprise Value
271.77B
Revenue
37.27B
Ranking
n/a
PE Ratio
59.10
Stock Price
$703.25
Market Cap Chart
Since August 11, 2015, Syngene International's market cap has increased from 62.11B to 279.96B, an increase of 350.75%. That is a compound annual growth rate of 16.28%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 1, 2025 | 279.96B | -18.00% |
| Dec 31, 2024 | 341.40B | 22.54% |
| Dec 29, 2023 | 278.60B | 19.79% |
| Dec 30, 2022 | 232.57B | -5.39% |
| Dec 31, 2021 | 245.81B | -3.08% |
| Dec 31, 2020 | 253.62B | 100.09% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
| Aug 11, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sun Pharmaceutical Industries | 4,159.97B |
| Divi's Laboratories | 1,772.40B |
| Cipla | 1,259.61B |
| Apollo Hospitals Enterprise | 1,071.20B |
| Mankind Pharma | 1,054.40B |
| Zydus Lifesciences | 1,001.35B |
| Aurobindo Pharma | 672.63B |
| Fortis Healthcare | 636.20B |